Skip to main content

Table 2 Clinical characteristics of patients and details of CHC and RHC and HBO treatment

From: Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis

Sex Age/Therapy Age/End of Follow-up Diagnosis Treatment HBO IndicationIndikation End of Therapy Time till Haematuria [m] RTOG/Gray before HBOT Admissions to Hospital Number blood transfusions Duration till HBO [m] HBO Treatments Follow Up [m] Events/Follow-up RTOG/Gray after HBO
M 68 70 PCA adj RC 08/2008 34 3 5 0 4 40 33 no relapse 0
M 82 86 PCA prim RC 07/2004 54 3 3 0 15 24 53 no relapse 0
M 73 81 PCA HDR RC 08/2002 11 4 4 2 33 24 100 1x haematuria 2007 3
W 71 83 CCA adj RC 07/1997 30 3 3 0 28 128 142 no relapse 0
M 80 86 PCA prim RC 07/1998 5 4 2 2 110 40 78 no relapse 0
M 71 76 PCA adj RC 01/1999 76 4 2 1 36 35 28 no relapse, †2010 0
W 86 90 UCA adj RC 01/1990 234 4 3 2 0 6 29 no relapse, †2012 0
M 80 83 PCA adj RC 01/2000 124 4 3 3 1 51 16 SRC 2010, †2012 4
M 65 72 PCA adj RC 03/2000 50 4 3 1 30 26 94 no relapse 0
M 61 63 PCA sal RC 02/2010 20 4 3 4 7 20 133 no relapse 0
M 22 33 RPSS comb RC/CC 01/1999 43 4 2 12 11 34 28 no relapse 0
M 73 78 PCA sal RC/RP 07/2007 14 3 2 2 1 48 68 no relapse 0
M 65 71 PCA adj RC/RP 07/2003 48 4 3 2 3 20 49 no relapse, †2011 0
W 49 56 LE prim CC 01/1974 362 3 4 0 40 40 86 1x haematuria 2008 3
M 39 49 WG prim CC 01/1993 120 4 3 1 4 17 136 no relapse 0
  1. †=deceased.